top of page

Protocolos y recomendaciones de sociedades científicas

output-onlinepngtools.png
info 1@3x.png
Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021
09/08/2021
Eng
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
04/08/2021
Eng
Holding gatherings during the COVID-19 pandemic: WHO policy brief
03/08/2021
Eng
Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021
03/08/2021
Eng
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
30/07/2021
Eng
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
30/07/2021
Eng
Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
15/07/2021
Eng
WHO technical consultation on oxygen access scale-up for COVID-19
14/07/2021
Eng
Safe Eid al Adha practices in the context of COVID-19
13/07/2021
Eng
COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women
12/07/2021
Eng
Infection prevention and control during health care when coronavirus disease (‎COVID-19)‎ is suspected or confirmed
12/07/2021
Eng
Therapeutics and COVID-19: living guideline
06/07/2021
Eng
Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: Interim guidance
02/07/2021
Eng
Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19
02/07/2021
Eng
Ethical Framework for WHO’s work in the ACT-Accelerator
01/07/2021
Eng
Protocol template to be used as template for observational study protocols for sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines.
01/07/2021
Eng
Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic
01/07/2021
Eng
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
25/06/2021
Eng
Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions
25/06/2021
Eng
Considerations for quarantine of contacts of COVID-19 cases
25/06/2021
Eng
Managing family risk: A facilitator’s toolbox for empowering families to manage risks during COVID-19 - Part 2
18/06/2021
Eng
A family toolbox for managing health and happiness during COVID-19 - Part 1
18/06/2021
Eng
Hypertension and COVID-19
17/06/2021
Eng
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
15/06/2021
Eng
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
15/06/2021
Eng
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
14/06/2021
Eng
Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women
10/06/2021
Eng
How to manage COVID-19 vaccines without VVM at vaccination service points?
03/06/2021
Eng
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables
01/06/2021
Eng
Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines
01/06/2021
Eng
Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic
01/06/2021
Eng
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
01/06/2021
Eng
Preventing and mitigating COVID-19 at work
19/05/2021
Eng
WHO COVID-19 infection prevention and control (IPC) pillar achievements.
14/05/2021
Eng
Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic
13/05/2021
Eng
AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine
10/05/2021
Eng
Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (‎SARI)‎ hospitalizations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design
06/05/2021
Eng
COVID-19 Exercise Programme - Drills for Vaccine Deployment
03/05/2021
Eng
Guía clínica para la atención al paciente long covid/covid persistente
01/05/2021
Esp
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief
26/04/2021
Eng
Expanding our understanding of post COVID-19 condition: report of a WHO webinar
24/04/2021
Eng
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience)
20/04/2021
Eng
Asthma and COVID-19: scientific brief
19/04/2021
Eng
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief
19/04/2021
Eng
Why are there extra doses of vaccine in the vaccine vial?
16/04/2021
Eng
WHO COVID-19 essential supplies forecasting tool (‎COVID-ESFT)
14/04/2021
Eng
Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets
12/04/2021
Eng
WHO COVID-19 infection prevention and control (IPC) pillar achievements. February 2020 – January 2021
06/04/2021
Eng
NO HACER en vacunas contra la COVID-19
31/03/2021
Esp
WHO-convened global study of origins of SARS-CoV-2: China Part
30/03/2021
Eng
Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine
17/03/2021
Eng
How to monitor and report COVID-19 vaccine side effects
15/03/2021
Eng
Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data
03/03/2021
Eng
WHO Living guideline: Drugs to prevent COVID-19
02/03/2021
Eng
COVID-19 vaccine checklist
01/03/2021
Eng
Health worker communication for COVID-19 vaccination flow diagram
01/03/2021
Eng
Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2
17/02/2021
Eng
Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19
15/02/2021
Eng
Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca
10/02/2021
Eng
Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF)
09/02/2021
Eng
Criterios para descartar infección aguda por SARS-CoV-2 tras la vacunación
08/02/2021
Esp
Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2
07/02/2021
Eng
Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance
03/02/2021
Eng
Background document on the mRNA-1273 vaccine (Moderna) against COVID-19
03/02/2021
Eng
Administración de la vacuna frente a COVID-19 en pacientes candidatos y receptores de trasplantes de órganos sólidos.
28/01/2021
Esp
Las nuevas cepas del SARS-CoV-2, ¿qué se sabe?
26/01/2021
Esp
Recomendaciones FACME sobre vacunación COVID-19 y trasplante de órganos
25/01/2021
Esp
Actualización - Estrategia de vacunación frente a COVID-19 en España
25/01/2021
Esp
INTEGRACIÓN DE LA SECUENCIACIÓN GENÓMICA EN LA VIGILANCIA DELSARS-CoV-2
22/01/2021
Esp
Actualización - Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19
22/01/2021
Esp
Strategies for Optimizing the Supply of Isolation Gowns
21/01/2021
Eng
WHO public health research agenda for managing infodemics
18/01/2021
Eng
Sequencing of SARS-CoV-2 - Version 1
18/01/2021
Eng
Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency
15/01/2021
Eng
Investigational COVID-19 Convalescent Plasma
15/01/2021
Eng
Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
14/01/2021
Eng
Posicionamiento de la Sociedad Española de inmunologia (SEI) sobre vacunación en pacientes que ya han superado la COVID-19
14/01/2021
Esp
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
14/01/2021
Eng
COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity
13/01/2021
Eng
Consideraciones acerca de las vacunas frente a la COVID-19 y la lactancia materna
13/01/2021
Esp
Recomendaciones FACME para la vacunación COVID-19 en niños y adolescentes
12/01/2021
Esp
Administración de la vacuna frente a COVID-19 en niños y adolescentes
12/01/2021
Esp
COVID-19 Rapid Response Team Guidance
08/01/2021
Eng
How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings
08/01/2021
Eng
Product Information as approved by the CHMP on 8 January 2021, pending endorsement by the European Commission
08/01/2021
Eng
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 - Version 3.6.0
08/01/2021
Eng
¿Cómo atender a pacientes con COVID-19?
07/01/2021
Esp
Recomendaciones FACME para la vacunación frente a COVID-19 en alérgicos
07/01/2021
Esp
Recomendaciones FACME para la vacunación COVID-19 en alérgicos
07/01/2021
Esp
Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic
07/01/2021
Eng
COVID-19 Vaccine Moderna - Product information
06/01/2021
Eng
CHMP summary of positive opinion for COVID-19 Vaccine Moderna
06/01/2021
Eng
Guidance on Providing Pediatric Well-Care During COVID-19
06/01/2021
Eng
Summary of the Risk Management Plan for COVID-19 Vaccine Moderna
06/01/2021
Eng
COVID-19 Guidance for Safe Schools
05/01/2021
Eng
Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic
05/01/2021
Eng
Resumen eficacia y seguridad vacuna Moderna
05/01/2021
Esp
Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication
04/01/2021
Eng
Guía Informativa para pacientes vacunas y vacunación COVID-19
04/01/2021
Esp
Recomendaciones FACME para la vacunación COVID-19 en pacientes con cáncer
30/12/2020
Esp
Cloth Face Coverings
30/12/2020
Eng
Recomendaciones FACME para la vacunación COVID-19 durante la lactancia materna
30/12/2020
Esp
Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic
30/12/2020
Eng
COVID-19 Testing Guidance
30/12/2020
Eng
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19
30/12/2020
Esp
Information for Pediatric Healthcare Providers
30/12/2020
Eng
Recomendaciones FACME para la vacunación frente a COVID-19 en pacientes con cáncer
30/12/2020
Esp
Vacunas frente a COVID-19 y lactancia materna
30/12/2020
Esp
Recomendaciones FACME para la vacunación COVID-19 en mujeres embarazadas
29/12/2020
Esp
Recomendaciones FACME para la vacunación frente a COVID-19 en mujeres embarazadas
29/12/2020
Esp
La ciencia nos ha dado las vacunas, entro todos haremos que sean eficaces
29/12/2020
Esp
Recomendaciones FACME para la vacunación COVID-19 en pacientes inmunosuprimidos
29/12/2020
Esp
Recomendaciones FACME para la vacunación frente a COVID-19 en grupos de potencial riesgo
29/12/2020
Esp
Preguntas y respuestas relacionadas con las vacunas frente a la Covid-19
29/12/2020
Esp
Recomendaciones FACME para la vacunación COVID-19 en pacientes anticoagulados o con trastornos de la coagulación
29/12/2020
Esp
Administración de la vacuna frente a COVID-19 en pacientes con inmunodeficiencias o en tratamiento inmunosupresor o inmunomodulador.
29/12/2020
Esp
Vacunación COVID-19 - Preguntas Comunes y Respuestas
28/12/2020
Esp
Etiquetado e indicaciones de seguridad para el uso y conservación de geles y soluciones hidroalcohólicos
28/12/2020
Esp
Recomendaciones y Posicionamiento sobre la vacunación frente a COVID-19 de la SEIMC en la población general y en particular en los más vulnerables
27/12/2020
Esp
Vacunación de la covid en el embarazo y lactancia
23/12/2020
Esp
COVID-19 in children and the role of school settings in transmission - Version 1
23/12/2020
Eng
Comirnaty : EPAR - All authorised presentations
22/12/2020
Eng
Comirnaty : EPAR - Public assessment report
22/12/2020
Eng
Posicionamiento y recomendaciones de la Sociedad Española de Inmunología en relación con la campaña de vacunación frente a COVID-19 en pacientes con inmunodeficiencias primarias o secundarias
22/12/2020
Esp
Vigilancia de la seguridad de las vacunas frente a la COVID-19
22/12/2020
Esp
Fundamento del uso de tocilizumab en pacientes con Covid. Beneficio vs riesgo - Versión 1
22/12/2020
Esp
Commission adopts Recommendation on EU coordinated approach to travel and transport in response to new variant of coronavirus in the UK
22/12/2020
Eng
COVID-19 vaccination and prioritisation strategies in the EU/EEA
22/12/2020
Eng
Comirnaty: EPAR - Product Information
21/12/2020
Eng
Recomendaciones GESITRA-IC-SEIMC-REIPI para el manejo clínico de receptores de trasplante de órgano sólido con COVID-19
21/12/2020
Esp
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19
21/12/2020
Eng
Información sobre productos sanitarios especialmente utilizados durante la COVID-19 que han sido detectados en el mercado y no cumplen la regulación
21/12/2020
Esp
Papel del remdesivir en pacientes con Covid-19 - Versión 1
21/12/2020
Esp
CHMP summary of positive apinion for Comirnaty
20/12/2020
Eng
COVID-19 rapid guideline: managing the long-term effects of COVID-19
18/12/2020
Eng
Coronavirus (covid-19): medidas de prevención y control de la infección
18/12/2020
Esp
Since advice in a crisis
18/12/2020
Esp
Proposal for a council recommendation on a common framework for the use, validation and mutual recognition of COVID-19 rapid antigen tests in the EU
18/12/2020
Eng
Vaccines and Related Biological Products Advisory Committee Meeting
17/12/2020
Eng
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities
17/12/2020
Eng
COVID-19 rapid guideline: vitamin D
17/12/2020
Eng
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities
16/12/2020
Eng
Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19
15/12/2020
Esp
Mitigating Staff Shortages
14/12/2020
Eng
Testing Healthcare Personnel
14/12/2020
Eng
Potential Exposure at Work
14/12/2020
Eng
Infection Control Guidance
14/12/2020
Eng
Navidad segura con las recomendaciones SEIMC
14/12/2020
Esp
El coronavirus, un invitado no deseado. Diez sensatas recomendaciones para estas fechas
14/12/2020
Esp
Coronavirus (COVID-19): evidencia relevante para cuidados críticos
12/12/2020
Esp
Resumen, eficacia y seguridad vacuna Oxford-AstraZeneca
12/12/2020
Esp
Coronavirus disease 2019 (COVID-19) and supply ofsubstances of human origin in the EU/EEA - 2nd update
10/12/2020
Eng
Posicionamiento SEIMC sobre "Pruebas de detección rápida de anticuerpos por inmunocromatografia para el autodiagnóstico de infección por SARS-CoV-2 (Covid-19)"
09/12/2020
Esp
Tests ràpids d’infeccions respiratòries pediàtriques
09/12/2020
Cat
Obesity Management and Treatment During COVID-19
09/12/2020
Eng
Supporting Healthy Nutrition and Physical Activity During the COVID-19 Pandemic
09/12/2020
Eng
Recomendaciones SEIMC para elmanejo clínico de pacientes con COVID-19
09/12/2020
Esp
Comunicado oficial tras la recomendación de la agencia reguladora de medicamentos y productos sanitarios de reino unido de no poner la vacuna contra la COVID-19 de Pfizer a aquellos que tienen antecedentes de reacciones graves a fármacos y/o alimentos
09/12/2020
Esp
Winter Holidays
09/12/2020
Eng
Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)
08/12/2020
Eng
Interim Guidance for Antigen Testing for SARS-CoV-2
05/12/2020
Eng
COVID-19 Interim Guidance: Return to Sports
04/12/2020
Eng
Guidance for Dental Settings
04/12/2020
Eng
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths
04/12/2020
Eng
Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings
03/12/2020
Eng
Care for Breastfeeding Women
03/12/2020
Eng
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel
02/12/2020
Eng
Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol
02/12/2020
Eng
Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection
02/12/2020
Eng
Guidance for Health Departments about COVID-19 Testing in the Community
01/12/2020
Eng
Staying safe from COVID-19 during winter
01/12/2020
Eng
Gestió de casos COVID-19 als centres educatius
01/12/2020
Cat
Medidas de protección personal frente al coronavirus SARS-CoV-2: conceptos sobre su utilización en el ámbito laboral
01/12/2020
Esp
CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2
01/12/2020
Eng
Know When to Delay your Travel to Avoid Spreading COVID-19
01/12/2020
Eng
Guia para la prevenció y control de la COVID-19 en industrias de la carne
30/11/2020
Esp
Recomendaciones de la AEP para la consideración de los niños en las reuniones de Navidad en el contexto de la pandemia
30/11/2020
Esp
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel
30/11/2020
Eng
Rapid hospital readiness checklist: Interim Guidance
26/11/2020
Eng
Uso de los test rápidos de antígeno para el diagnóstico de la infección SARS-CoV-2 traducido por el Consejo de Dentistas
26/11/2020
Esp
Know When to Delay your Travel to Avoid Spreading COVID-19
25/11/2020
Eng
Contact Tracing for COVID-19
23/11/2020
Eng
Prioritizing Case Investigations and Contact Tracing for COVID-19 in High Burden Jurisdictions
23/11/2020
Eng
Investigating a COVID-19 Case
23/11/2020
Eng
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings
23/11/2020
Eng
Strategies for Optimizing the Supply of N95 Respirators
23/11/2020
Eng
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings
23/11/2020
Eng
Polling Locations and Voters
23/11/2020
Eng
Strategies for Optimizing the Supply of Facemasks
23/11/2020
Eng
Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19
22/11/2020
Eng
COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19
20/11/2020
Eng
Therapeutics and COVID-19: living guideline - 2nd Version
20/11/2020
Eng
Priority medical devices list for the COVID-19 response and associated technical specifications
20/11/2020
Eng
Preparing for COVID-19 in Nursing Homes
20/11/2020
Eng
Continuity of essential health services: Facility assessment tool
20/11/2020
Eng
Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
20/11/2020
Eng
Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: non-US Healthcare Settings
19/11/2020
Eng
Actualización - Guía de test COVID-19 del Consejo General de Dentistas de España
19/11/2020
Esp
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK
19/11/2020
Eng
Cleaning, Disinfection, and Hand Hygiene in Schools – a Toolkit for School Administrators
19/11/2020
Eng

Fuentes​

OMS

Unión Europea

semFYC

CAMFiC

SEOM

Consejo General de Colegios Farmacéuticos de España

COEC

Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid

SEPAR

SEMG

RCPCH

ecdc

AEC

SEC

SERAM

IACS

NICE

Consejo General de  Dentistas de España

Fundación Dental Española

ESC

CERCP

ESC

AOMRC

FEMEDE

bottom of page